CREO — Creo Medical Cashflow Statement
0.000.00%
Last trade - 00:00- £59.81m
- £51.51m
- £6.00m
Annual cashflow statement for Creo Medical, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -24.6 | -26.9 | -21.7 | -27.8 | -17.5 |
| Depreciation | |||||
| Non-Cash Items | -2.65 | -2.4 | -1.9 | 1.5 | -2 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.33 | 1.3 | -1.4 | 1.6 | -0.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -26 | -24.9 | -21.6 | -22.2 | -19.1 |
| Capital Expenditures | -6.12 | -3.3 | -1.6 | -0.4 | -0.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.72 | -2.7 | -16.7 | 15.7 | 20.8 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.84 | -6 | -18.3 | 15.3 | 19.9 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 32 | 0.4 | 29.8 | 16.2 | -0.7 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.56 | -30.4 | -10.1 | 9.3 | 0.1 |